BEXIMCO Pharmaceuticals Ltd. has been a significant company in the industry. It has made huge contributions to the Bangladeshi pharmaceutical industry. Beyond this, the company has expanded its roots to different locations. Even in the year to come, it aims to make its medicine available in Saudi Arabia. Identified as the leader in the private sector in Bangladesh, the pharma company will be able to do so through a joint investment of Saudi Arabia and Bangladesh. This measure is expected to give a boost to the pharmaceutical industry of the country in the Middle East.
Announcement for Drug Production in Saudi Arabia
In March 2023, Salman F Rahman, the most prominent businessman and policy maker in Bangladesh, said that for drug production, technical assistance and manpower are required. He is also one of the owners of BEXIMCO Pharmaceuticals Ltd. The Private Industry and Investment Adviser of the Prime Minister further said that the requirements will be sourced from Bangladesh. This announcement was made after Mr. Rahman visited BEXIMCO Pharmaceuticals Ltd. He was accompanied by a delegation which was led by Majid bin Abdullah Al-kassabi, Minister of Commerce, Saudi Arabia.
Investing Faith in Medicine Produced in Bangladesh
According to Salman F Rahman, Bangladesh comprises pharma companies that make qualitative medicine. At BEXIMCO Pharmaceuticals Ltd. as well, this objective is upheld. The leader in the private sector in the country has been producing medicine with 100 percent quality. Also, it practices international measures for the export of drugs.
Given the quality and the implementation of the best measures, the people within Bangladesh can certainly trust the produced drugs. Moreover, at an international level too, other consumers can have faith in the medicine. They can expect greater improvement in their health. Even for conditions for which drugs are unavailable in the country, this move will bring hope.
Aiming to Enhance Pharma Sector in Saudi Arabia
BEXIMCO Pharmaceuticals Ltd. believes that, owing to health concerns, it is a nation’s responsibility to make the best medicine available to its people. Considering such an objective, Saudi Arabia aims to make qualitative medicine accessible to its citizens. With companies like BEXIMCO Pharmaceuticals Ltd., this aim can be achieved. As the pharma sector of the country in the Middle East improves, citizens will be able to consume effective medicine.
Setting up a Factory for Medicine Production in Saudi Arabia
Remarkably, BEXIMCO is a conglomerate that aims to export good-quality medicine to more than 160 countries. As the leader in the private sector in Bangladesh, it understands its greater responsibility. It is determined to make a positive impact across the globe. Given its dedication to improving the health of people, the company has made a significant move by planning to set up this factory.
To produce high-quality medicine by BEXIMCO Pharmaceuticals Ltd. in Saudi Arabia, a factory is being set up. It will be established in sync with the joint investment of Bangladesh and the Middle Eastern nation. Most resources are expected to be sourced from Bangladesh, as per Nazmul Hasan Papon, Managing Director, BEXIMCO Pharmaceuticals Ltd. These resources will mainly comprise raw materials required for producing medicine.
This factory will have sufficient equipment to produce medicine in bulk. Moreover, it will be capable of producing 30 types of drugs. Thus, various disorders, diseases, and symptoms will be treated in Saudi Arabia. Gradually, the health of its citizens will be better focused by the pharma sector.
Reliance on BEXIMCO Pharma for Effective Drugs
BEXIMCO Pharma has made a considerable name for itself in Bangladesh. The pharmaceutical sector can make achievements overall, owing to the practices of companies like this one.
Saudi Arabia’s reliance on the leading pharma company in Bangladesh is expected to yield the desired goals. By 2024, the factory will possibly begin functioning. Considering the norms practiced by BEXIMCO, the factory will be well-regulated. There will be a stringent focus on the quality of medicine.
To Summarize
As the leader in the private sector in Bangladesh, BEXIMCO Pharma is a company that spreads the impact of its drugs worldwide. Its medicine will soon be made available in Saudi Arabia as well. While this will bring a greater scope for health improvement in the Middle Eastern country, it will also strengthen ties with Bangladesh. At the international level, health will become a better-focused goal.